Canada· CA-DIN-02534797
PENTACEL
A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus product containing haemophilus influenzae type b-prp + tetanus protein + filamentous haemagglutinin + poliovirus type 1 mahoney (inactivated), registered in Canada by SANOFI PASTEUR LIMITED. The same ATC class is registered in 8 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus is registered in 8 of 19 countries.
Countries holding a registration under ATC J07CA06 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus · ATC J07CA06
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- HAEMOPHILUS INFLUENZAE TYPE B-PRP + TETANUS PROTEIN + FILAMENTOUS HAEMAGGLUTININ + POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)
- Manufacturer
- SANOFI PASTEUR LIMITED
- Country
- Canada (CA)
- ATC code
- J07CA06
- ATC class
- Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07CA06
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus, as other registers publish it.
- PolandInfanrix - IPV + HibGlaxoSmithKline Biologicals S.A.
- SwitzerlandInfanrix DTPa-IPV+Hib
- SwitzerlandInfanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer InjektionssuspensionGlaxoSmithKline AG
- BelgiumInfanrix IPV + HibGlaxoSmithKline Biologicals
- SpainINFANRIX-IPV+HIB POLVO Y SUSPENSION PARA SUSPENSION INYECTABLEGlaxosmithkline S.A.
- FinlandInfanrix-Polio+HibGlaxoSmithKline Biologicals SA
- DenmarkInfanrix-Polio+HibGlaxoSmithKline Pharma A/S
- FinlandPediacelSanofi Pasteur Europe
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2c5ba09-7b5d-467d-ae16-5d1a166540fd GET /v1/drugs/f2c5ba09-7b5d-467d-ae16-5d1a166540fd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02534797",
"form": "SUSPENSION",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J07CA06",
"schedule": [
"Schedule D"
],
"drug_code": "102369",
"strengths": [
"10 MCG",
"30 MCG",
"20 MCG",
"29 UNIT",
"5 MCG",
"15 LF",
"7 UNIT",
"3 MCG",
"5 LF",
"26 UNIT"
],
"ahfs_class": null,
"substances": [
"HAEMOPHILUS INFLUENZAE TYPE B-PRP",
"TETANUS PROTEIN",
"FILAMENTOUS HAEMAGGLUTININ",
"POLIOVIRUS TYPE 1 MAHONEY (INACTIVATED)",
"FIMBRIAE",
"DIPHTHERIA TOXOID",
"POLIOVIRUS TYPE 2 MEF1 (INACTIVATED)",
"PERTACTIN",
"TETANUS TOXOID",
"POLIOVIRUS TYPE 3 SAUKETT (INACTIVATED)",
"PERTUSSIS TOXOID"
],
"product_categorization": null
}See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.